Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
YPrime Wins Two Clinical Trials Arena Excellence Awards for Innovation in AI and Sustainable eCOA Practices
-
Papa Appoints Dr. Thomas Carlough as Chief Technology Officer, Strengthens Leadership Team to Accelerate the Next Generation of In-Home Support
-
KBW Appoints Stephen Glagola as Managing Director and Senior Research Analyst Covering Digital Asset Companies
-
Scioto County Career Technical Center Conducts First-Ever Online GovDeals Real Estate Sale
-
Infragistics Predicts How AI Will Shape a New Era of Software Development
-
Hudson Technologies Selected to Support California Air Resources Board’s Refresh Pilot Program for Refrigerant Recovery & Reclamation
-
Valeo - Voting rights - November 2025
-
AlphaTON Capital World Tour Lands at Abu Dhabi Finance Week
-
Zhongsheng Fiberglass to Debut Integrated Fire Safety Matrix and Eco-Friendly Industrial Fiberglass Solutions at INTERSCHUTZ 2026
-
TransUnion Unveils Enhancements to Next-Generation Device Risk Solution to Combat Rising Fraud Losses
-
Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings
-
STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico
-
Vivid Seats Upgrades Mobile Experience with Immersive Tools for Smarter Shopping
-
Green Rain Energy Holdings, Inc. (OTC: GREH) Provides Strategic Corporate Update as Company Prioritizes Its Fully Funded EV Charging Expansion Across 29 Premier U.S. Hotels
-
AMERICAN WRITERS MUSEUM’S NEW SPECIAL EXHIBIT AMERICAN PROPHETS: WRITERS, RELIGION, AND CULTURE NOW OPEN THROUGH NOVEMBER 2026
-
Vivid Seats Upgrades Mobile Experience with Immersive Tools for Smarter Shopping
-
Caisse Française de Financement Local EMTN 2025-19
-
TWG Announces Pricing of $5.04 million Public Offering
-
Rodents on the run: Orkin Canada releases 2025 list of Rattiest Cities
-
Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026
-
FOXO Technologies Inc. Subsidiary, Myrtle Recovery Centers, Recognized by the Rural Health Association of Tennessee for Outstanding Community Impact
-
Regula’s Database Expands to 16,000 ID Templates, as New 2026 Passport Standards Emerge
-
3D Systems Announces $31 Million Equitization Transaction
-
Blue Gold Announces Successful Smart Contract Audit by Nethermind, Strengthening Security and Transparency Ahead of Standard Gold Coin Launch on Base
-
Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use
-
Inspira Technologies Granted Patent in Japan for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use
-
Sesen Launches TrialS, a Next Generation Platform for Regulatory, Clinical, and Labeling Translation Validation
-
Rabbet Launches Central Inbox to Eliminate Document Chaos for Real Estate Developers
-
Bitget Reports Record 4,468% Surge in Tokenized US Stock Futures During Earnings Season
-
Genetec releases 2026 global State of Physical Security Report
-
Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism
-
Global Uranium Corp. Announces Completion of Geological Mapping at the Airline Project in Wyoming
-
Empower Semiconductor Expands Global Footprint with New Silicon Valley Headquarters and Munich R&D Office
-
Airia Launches Natural Language Agent Building Capabilities, Eliminating Barriers to AI Agent Development
-
HydroGraph Announces Appointment of James Baker to Technical Advisory Board
-
Tessera Therapeutics Announces Chief Financial Officer (CFO) Transition and Appointment of Kathy Bergsteinsson as CFO
-
IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Nikolas Perrault, Executive Chairman of Fairchild Gold Corp.
-
Nexxen Launches Nexxen Sports, Connecting Brands with Highly Engaged Live Sports Viewers
-
Teva Pharmaceuticals Submits New Drug Application to FDA for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
-
LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
-
Blaqclouds Unveils State-of-the-Art Podcast Studio in Colorado to Spotlight High-Utility Companies and Real-World Crypto Projects
-
RTI to Showcase Connext Drive 4.0 at CES 2026
-
Maxus Mining Announces Positive Results from 2025 Exploration Program at Penny Copper Project in British Columbia
-
From Vision to Execution: CEO Kevin Kelly Reflects on Cycurion’s Strategic Achievements in 2025 in New Interview
-
New York Gastroenterology Associates Taps Proscia for Digital Pathology
-
Evotrex to Debut World’s First Power-Generating RV Trailer at CES 2026
-
AnswersNow Expands Virtual Autism Therapy and Caregiver Training Services to Colorado
-
Chijet Motor Company Inc. Announces Official Name Change to “Digital Currency X Technology Inc.” and New Ticker Symbol “DCX” Effective December 10, 2025
-
JFB Construction CEO Purchases Approximately $100,000 in the Company’s Common Stock on the Open Market
-
AskBio’s AB-1005 and AB-1002 Receive Pioneering Regenerative Medical Product Designation in Japan
